NAPROXEN PLUS

NAPROXEN PLUS

Naproxen BP + Esomeprazole
(as Esomeprazole Magnesium Trihydrate BP)

NAPROXEN PLUS

Naproxen BP + Esomeprazole
(as Esomeprazole Magnesium Trihydrate BP)

Naproxen Plus 500+20

Naproxen BP 500 mg + Esomeprazole 20 mg
(as Esomeprazole Magnesium Trihydrate BP)

Indications

Naproxen Plus tablet is indicated for the relief of signs & symptoms of-

  • Osteoarthritis

  • Rheumatoid arthritis

  • Ankylosing spondylitis &

  • To decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers.

This consists of an immediate release Esomeprazole Magnesium layer & an enteric-coated Naproxen core. As a result, Esomeprazole is released first into the stomach, prior to the dissolution of Naproxen in the small intestine.

Naproxen is a NSAID with analgesic & antipyretic properties. The mechanism of action of Naproxen is to inhibit the prostaglandin synthesis. Esomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/k+ -ATPase in the gastric parietal cell by acting specifically on the proton pump, Esomeprazole blocks the final step in acid production, thus reducing gastric acidity.

Naproxen Plus 375+20

Naproxen BP 375 mg + Esomeprazole 20 mg
(as Esomeprazole Magnesium Trihydrate BP)

Indications

Naproxen Plus tablet is indicated for the relief of signs & symptoms of-

  • Osteoarthritis

  • Rheumatoid arthritis

  • Ankylosing spondylitis &

  • To decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers.

This consists of an immediate release Esomeprazole Magnesium layer & an enteric-coated Naproxen core. As a result, Esomeprazole is released first into the stomach, prior to the dissolution of Naproxen in the small intestine.

Naproxen is a NSAID with analgesic & antipyretic properties. The mechanism of action of Naproxen is to inhibit the prostaglandin synthesis. Esomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/k+ -ATPase in the gastric parietal cell by acting specifically on the proton pump, Esomeprazole blocks the final step in acid production, thus reducing gastric acidity.